Related Experiment Video
Updated: May 22, 2026
08:57
Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization
Published on: October 6, 2019
Evidence of association between interferon regulatory factor 5 gene polymorphisms and asthma
Chuan Wang1, Matthew J Rose-Zerilli, Gerard H Koppelman
1Department of Medical Sciences, University Hospital, Uppsala University, Uppsala, Sweden. chuan.wang@medsci.uu.se
Gene
|May 23, 2012
Summary
Interferon regulatory factor 5 (IRF5) gene variations are linked to asthma development and symptom severity, particularly in nonatopic individuals. These IRF5 alleles show opposite associations compared to autoimmune disorders.
Area of Science:
- Immunogenetics
- Respiratory Medicine
- Genetic Epidemiology
Background:
- Asthma is a chronic respiratory disease characterized by inflammation.
- Asthma exacerbations are frequently linked to respiratory infections.
- Interferon regulatory factor 5 (IRF5) plays a role in immune responses.
Purpose of the Study:
- To investigate the transmission patterns of IRF5 gene polymorphisms in asthma.
- To determine the association between IRF5 and asthma susceptibility and severity.
- To explore the differential role of IRF5 in asthma versus autoimmune disorders.
Main Methods:
- Analysis of ten IRF5 gene polymorphisms in two asthmatic family cohorts.
- Haplotype analysis to identify common genetic patterns.
- Stratified analysis of asthmatic subgroups, including nonatopic individuals.
Main Results:
- A common IRF5 haplotype was significantly associated with asthma and symptom severity.
- The association was more pronounced in nonatopic asthmatic individuals.
- Risk alleles for asthma were generally opposite to those for autoimmune disorders.
Conclusions:
- This study provides the first evidence linking IRF5 gene polymorphisms to asthma.
- IRF5 alleles may have distinct roles in the pathogenesis of asthma and autoimmune diseases.
- Further research into IRF5's role in respiratory inflammation is warranted.
Related Concept Videos
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:29Asthma-I: Introduction
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
01:13Asthma III: Clinical Manifestations
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...